Riskpilot← Back to searchSign inGet full accessMedCush AB
ABIn liquidationOrg 5591514657Specialised design activities · NACE 7410Est. 20181 employees
Revenue 2022
SEK 0
EBITDA margin
—
-300% vs 2021
Equity ratio
100.0%
Financial strength
Net profit 2022
SEK -334K
-33300% vs 2021
| Revenue | SEK 0 | — |
| EBITDA | SEK -4K | -300% |
| Net profit | SEK -334K | -33300% |
| Total assets | SEK 50K | -87% |
| Equity | SEK 50K | +11% |
| Employees | 1 | — |
Legal name
MedCush AB
Org number
5591514657
Legal form
Aktiebolag
NACE code
7410 · Specialised design activities
Founded
5 mars 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Företaget ska bedriva innovation, utveckling, försäljning, konsultation kring medicintekniska produkter, förvaltning av värdepapper, fastigheter, patent samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | — | — | −1 | −4 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −330 |
| EBIT | 0 | 0 | 0 | −1 | −334 |
| Net financials | −2 | −2 | −2 | — | — |
| Profit before tax | −1 | −1 | −1 | −1 | −334 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 | −1 | −1 | −1 | −334 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 317 | 419 | 419 | 381 | 50 |
| Equity | 49 | 48 | 48 | 45 | 50 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 268 | 371 | 371 | 336 | 0 |
| Total debt | 268 | 371 | 371 | 336 | — |
EBITDA margin
-400000.0%
This company
15.8%
Market median
-2531746% vs market
20182022
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20182022
Return on equity
-668.0%
This company
18.4%
Market median
-3730% vs market
20182022
Net profit margin
-33400000.0%
This company
8.1%
Market median
-412345779% vs market
20182022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182022
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-03-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UM Liquidator | Liquidator | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedCush AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulla Margot Yvonne Roos | Liquidator | 0 companies |